<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "http://dtd.nlm.nih.gov/publishing/2.0/journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="2.0">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JMIR</journal-id>
      <journal-id journal-id-type="nlm-ta">J Med Internet Res</journal-id>
      <journal-title>Journal of Medical Internet Research</journal-title>
      <issn pub-type="epub">1438-8871</issn>
      <publisher>
        <publisher-name>JMIR Publications</publisher-name>
        <publisher-loc>Toronto, Canada</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">v23i11e30394</article-id>
      <article-id pub-id-type="pmid">34792480</article-id>
      <article-id pub-id-type="doi">10.2196/30394</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Practice Effects of Mobile Tests of Cognition, Dexterity, and Mobility on Patients With Multiple Sclerosis: Data Analysis of a Smartphone-Based Observational Study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Kukafka</surname>
            <given-names>Rita</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Block</surname>
            <given-names>Valerie</given-names>
          </name>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Lindemann</surname>
            <given-names>Michael</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib id="contrib1" contrib-type="author">
          <name name-style="western">
            <surname>Woelfle</surname>
            <given-names>Tim</given-names>
          </name>
          <degrees>MSc, MD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0001-6279-4158</ext-link>
        </contrib>
        <contrib id="contrib2" contrib-type="author">
          <name name-style="western">
            <surname>Pless</surname>
            <given-names>Silvan</given-names>
          </name>
          <degrees>MSc</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-9660-9077</ext-link>
        </contrib>
        <contrib id="contrib3" contrib-type="author">
          <name name-style="western">
            <surname>Wiencierz</surname>
            <given-names>Andrea</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff3" ref-type="aff">3</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0001-8786-7915</ext-link>
        </contrib>
        <contrib id="contrib4" contrib-type="author">
          <name name-style="western">
            <surname>Kappos</surname>
            <given-names>Ludwig</given-names>
          </name>
          <degrees>MD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0003-4175-5509</ext-link>
        </contrib>
        <contrib id="contrib5" contrib-type="author">
          <name name-style="western">
            <surname>Naegelin</surname>
            <given-names>Yvonne</given-names>
          </name>
          <degrees>MD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-1315-4100</ext-link>
        </contrib>
        <contrib id="contrib6" contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Lorscheider</surname>
            <given-names>Johannes</given-names>
          </name>
          <degrees>MD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <address>
            <institution>Research Center for Clinical Neuroimmunology and Neuroscience Basel</institution>
            <institution>University of Basel, University Hospital Basel</institution>
            <addr-line>Spitalstrasse 2</addr-line>
            <addr-line>Basel, 4056</addr-line>
            <country>Switzerland</country>
            <phone>41 612652525</phone>
            <email>johannes.lorscheider@usb.ch</email>
          </address>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0003-1100-2506</ext-link>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution>Research Center for Clinical Neuroimmunology and Neuroscience Basel</institution>
        <institution>University of Basel, University Hospital Basel</institution>
        <addr-line>Basel</addr-line>
        <country>Switzerland</country>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution>Department of Neurology</institution>
        <institution>University Hospital Basel</institution>
        <addr-line>Basel</addr-line>
        <country>Switzerland</country>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <institution>Clinical Trial Unit</institution>
        <institution>Department of Clinical Research</institution>
        <institution>University of Basel, University Hospital Basel</institution>
        <addr-line>Basel</addr-line>
        <country>Switzerland</country>
      </aff>
      <author-notes>
        <corresp>Corresponding Author: Johannes Lorscheider <email>johannes.lorscheider@usb.ch</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>11</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>11</month>
        <year>2021</year>
      </pub-date>
      <volume>23</volume>
      <issue>11</issue>
      <elocation-id>e30394</elocation-id>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>5</month>
          <year>2021</year>
        </date>
        <date date-type="rev-request">
          <day>28</day>
          <month>6</month>
          <year>2021</year>
        </date>
        <date date-type="rev-recd">
          <day>23</day>
          <month>8</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>9</month>
          <year>2021</year>
        </date>
      </history>
      <copyright-statement>©Tim Woelfle, Silvan Pless, Andrea Wiencierz, Ludwig Kappos, Yvonne Naegelin, Johannes Lorscheider. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 18.11.2021.</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
        <p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.</p>
      </license>
      <self-uri xlink:href="https://www.jmir.org/2021/11/e30394" xlink:type="simple"/>
      <abstract>
        <sec sec-type="background">
          <title>Background</title>
          <p>Smartphones and their built-in sensors allow for measuring functions in disease-related domains through mobile tests. This could improve disease characterization and monitoring, and could potentially support treatment decisions for multiple sclerosis (MS), a multifaceted chronic neurological disease with highly variable clinical manifestations. Practice effects can complicate the interpretation of both improvement over time by potentially exaggerating treatment effects and stability by masking deterioration.</p>
        </sec>
        <sec sec-type="objective">
          <title>Objective</title>
          <p>The aim of this study is to identify short-term learning and long-term practice effects in 6 active tests for cognition, dexterity, and mobility in user-scheduled, high-frequency smartphone-based testing.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>We analyzed data from 264 people with self-declared MS with a minimum of 5 weeks of follow-up and at least 5 repetitions per test in the Floodlight Open study, a self-enrollment study accessible by smartphone owners from 16 countries. The collected data are openly available to scientists. Using regression and bounded growth mixed models, we characterized practice effects for the following tests: <italic>electronic Symbol Digit Modalities Test (e-SDMT)</italic> for cognition; <italic>Finger Pinching</italic> and <italic>Draw a Shape</italic> for dexterity; and <italic>Two Minute Walk</italic>, <italic>U</italic>-<italic>Turn</italic>, and <italic>Static Balance</italic> for mobility.</p>
        </sec>
        <sec sec-type="results">
          <title>Results</title>
          <p>Strong practice effects were found for <italic>e-SDMT</italic> (n=4824 trials), <italic>Finger Pinching</italic> (n=19,650), and <italic>Draw a Shape</italic> (n=19,019) with modeled boundary improvements of 40.8% (39.9%-41.6%), 86.2% (83.6%-88.7%), and 23.1% (20.9%-25.2%) over baseline, respectively. Half of the practice effect was reached after 11 repetitions for <italic>e-SDMT</italic>, 28 repetitions for <italic>Finger Pinching</italic>, and 17 repetitions for <italic>Draw a Shape</italic>; 90% was reached after 35, 94, and 56 repetitions, respectively. Although baseline performance levels were highly variable across participants, no significant differences between the short-term learning effects in low performers (5th and 25th percentile), median performers, and high performers (75th and 95th percentile) were found for <italic>e-SDMT</italic> up to the fifth trial (β=1.50-2.00). Only small differences were observed for <italic>Finger Pinching</italic> (β=1.25-2.5). For <italic>U</italic>-<italic>Turn</italic> (n=15,051) and <italic>Static Balance</italic> (n=16,797), only short-term learning effects could be observed, which ceased after a maximum of 5 trials. For <italic>Two Minute Walk</italic> (n=14,393), neither short-term learning nor long-term practice effects were observed.</p>
        </sec>
        <sec sec-type="conclusions">
          <title>Conclusions</title>
          <p>Smartphone-based tests are promising for monitoring the disease trajectories of MS and other chronic neurological diseases. Our findings suggest that strong long-term practice effects in cognitive and dexterity functions have to be accounted for to identify disease-related changes in these domains, especially in the context of personalized health and in studies without a comparator arm. In contrast, changes in mobility may be more easily interpreted because of the absence of long-term practice effects, even though short-term learning effects might have to be considered.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>multiple sclerosis</kwd>
        <kwd>digital biomarkers</kwd>
        <kwd>practice effects</kwd>
        <kwd>learning effects</kwd>
        <kwd>learning curves</kwd>
        <kwd>nonlinear mixed models</kwd>
        <kwd>quantile regression</kwd>
        <kwd>information processing speed</kwd>
        <kwd>symbol digit modalities test</kwd>
        <kwd>smartphones</kwd>
        <kwd>wearable electronic devices</kwd>
        <kwd>mobile phones</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction">
      <title>Introduction</title>
      <sec>
        <title>Background</title>
        <p>Multiple sclerosis (MS) is a multifaceted and variable chronic autoimmune neurological disease affecting approximately 2.3 million people worldwide [<xref ref-type="bibr" rid="ref1">1</xref>]. It is among the most common causes of nontraumatic disabilities in young adults [<xref ref-type="bibr" rid="ref2">2</xref>].</p>
        <p>MS progresses in different phases with highly variable speed and severity. To optimize treatment strategies, timely and precise monitoring of patients’ disease status is essential. As MS affects multiple functional domains, a range of validated clinical tests are used: for cognition, the Symbol Digit Modalities Test (SDMT) measures mental processing speed and is highly established as a screening tool for cognitive impairment in MS [<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref>]. The 9-hole peg test (9HPT) is routinely used to measure dexterity [<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref>], and the timed 25-foot walk (T25FW) is used to measure mobility [<xref ref-type="bibr" rid="ref7">7</xref>]. Usually, stable patients with MS have half-yearly to yearly clinical routine visits with neurologic examinations and regular magnetic resonance imaging (MRI), limiting insight into symptom fluctuations and reversible deficits [<xref ref-type="bibr" rid="ref8">8</xref>].</p>
        <p>Wearable technologies, such as smartphones and smartwatches, are expected to capture more representative data at a higher resolution not only in the patients’ natural environments in MS but also in other neurological diseases such as Parkinson disease and Huntington disease [<xref ref-type="bibr" rid="ref9">9</xref>-<xref ref-type="bibr" rid="ref11">11</xref>]. Data can be collected passively during the patient’s everyday activities (eg, capturing step counts, turn speed, or keyboard dexterity [<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref13">13</xref>]) or actively during specific functional tests [<xref ref-type="bibr" rid="ref14">14</xref>-<xref ref-type="bibr" rid="ref16">16</xref>]. They can possibly improve both clinical trials by providing more sensitive outcome measures and clinical practice by allowing more personalized disease course monitoring [<xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref17">17</xref>].</p>
        <p>Acknowledged difficulties in interpreting the results of repeated tests are learning and practice effects, especially in neuropsychology [<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref>]. Without a comparator, it is difficult to disentangle whether longitudinal improvement constitutes remission, practice, or treatment effects. In the same light, disease progression and worsening of disability may be masked by practice effects when specific tests feign stability. These issues have been adequately addressed by control groups in randomized controlled trials [<xref ref-type="bibr" rid="ref20">20</xref>]. For trials without control groups and for intraindividual comparisons—a cornerstone of personalized medicine—interpretation remains challenging. Furthermore, practice effects hamper test-retest reliability, which is illustrated by recommendations to discard the results from 3 prebaseline repetitions of the MS functional composite [<xref ref-type="bibr" rid="ref21">21</xref>]. However, more recently, it has been suggested that person-specific learning curves can be used as new outcome measures, leveraging the information inherent in practice effects [<xref ref-type="bibr" rid="ref14">14</xref>].</p>
      </sec>
      <sec>
        <title>Objective</title>
        <p>The aim of this analysis is to examine short-term learning and long-term practice effects in high-frequency smartphone-based tests representative of the assessment of 3 domains often affected by MS: cognition, dexterity, and mobility.</p>
      </sec>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Study Data and Participant Selection</title>
        <p>We used publicly available data from the <italic>Floodlight Open</italic> study, which collects smartphone-based test data from self-declared persons with MS with a number of different tests implemented in the Floodlight Open app [<xref ref-type="bibr" rid="ref22">22</xref>]. The study is the successor of a small, closed feasibility study [<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref17">17</xref>], and the data are openly available to researchers [<xref ref-type="bibr" rid="ref23">23</xref>]. Currently, several phase 3 studies are using variations of the Floodlight app as part of their test batteries, for example, the CONSONANCE trial, a single-arm interventional trial evaluating ocrelizumab treatment in participants with progressive MS (NCT03523858) [<xref ref-type="bibr" rid="ref17">17</xref>]. Recruitment for <italic>Floodlight Open</italic> started in April 2018, and some participants have been using the app continuously since then, amounting to more than 3 years of follow-up. However, most patients have only used the app for a very short time, leading to a strong right-skewness of the distribution of follow-up times. Among the 1147 patients who have performed at least one smartphone-based <italic>e</italic>-S<italic>DMT</italic> test in the period we examined, the median number of repetitions was 2, the IQR was 1-4 and the range was 1-119.</p>
        <p>We included data up to and including July 31, 2021, and focused our analyses on the following 6 tests [<xref ref-type="bibr" rid="ref9">9</xref>]: <italic>e-SDMT</italic> for cognition; <italic>Finger Pinching</italic> and <italic>Draw a Shape</italic> for dexterity; <italic>Two Minute Walk</italic>, <italic>U-Turn</italic>, and <italic>Static Balance</italic> for mobility. The dexterity tests have been shown to correlate with the 9HPT, the first 2 mobility tests with the T25FW and <italic>Static Balance</italic> with the Berg Balance Scale [<xref ref-type="bibr" rid="ref9">9</xref>]. The Floodlight Open app allows performing <italic>e-SDMT</italic> up to a weekly frequency and all other tests up to a daily frequency, but the actual frequency was completely determined by the participant’s choice. For dexterity tests, the left and right hands were alternated.</p>
        <p>The <italic>e-SDMT</italic> consisted of consecutively tapping symbol-corresponding digits on a number pad on the smartphone screen as quickly as possible for 60 seconds. Thus, there was a dexterity component that may potentially introduce bias. Floodlight’s <italic>e-SDMT</italic> included a second step termed <italic>baseline</italic>, simply showing digits instead of symbols, asking users to consecutively tap these digits on the same number pad for 15 seconds, without the symbol-association task. Using this second step by taking the quotient of the correct responses of the main test and the <italic>baseline</italic> potentially corrects for dexterity and reaction speed, representing only the true information processing speed.</p>
        <p>Participants were selected for each test separately if at least 5 repetitions per test and at least 5 weeks between their first and last repetitions were available. This yielded slightly different but largely overlapping subsets of participants for each test.</p>
      </sec>
      <sec>
        <title>Statistical Analysis</title>
        <sec>
          <title>Short-term Learning and Long-term Practice Effects</title>
          <p>First, summary analyses were performed to investigate the mean scores of the first, fifth, and last trials of each test. We assumed that improvements up to the fifth score were more likely due to short-term learning effects, where participants learned to execute a test, and improvements from the fifth trial onward were more likely because of long-term practice effects. Naturally, these effects are intertwined, but using the fifth trial as the baseline was supported by Solari et al [<xref ref-type="bibr" rid="ref24">24</xref>].</p>
          <p>To examine group differences in baseline performances and potential short-term learning effects in low and high performers, linear quantile regression was performed on each test for the first 5 trials for the 5th, 25th, 50th, 75th, and 95th percentiles. Quantile regression <italic>P</italic> values were corrected with the Bonferroni method, and the 5 slopes were compared with an analysis of variance (ANOVA)–type test.</p>
          <p>Long-term practice effects were assumed for tests with a significant mean difference from the fifth to the last score. The positive association of this difference with the number of repetitions (log-transformed to account for the strong right-skewness) adjusted for the potential confounders, age, first score, and fifth score, was considered as an additional indicator of long-term practice effects.</p>
        </sec>
        <sec>
          <title>Long-term Learning Curve Analysis</title>
          <p>For tests suggestive of long-term practice effects that meet the 2 abovementioned criteria, learning curve analysis was performed with 1 nonparametric and 3 parametric mixed effect models of increasing complexity, each modeling performance as a function of repetition, grouping by patient for cognition and mobility and by hand for dexterity. The performance of the 4 models was compared using both root mean squared error (RMSE) and the number of (effective) <italic>df</italic> used.</p>
          <p>For the nonparametric model, smoothing splines calculated by generalized additive models were fitted to examine the unbiased shape of the potential learning curves, exhibiting different effective <italic>df</italic> per test [<xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref26">26</xref>].</p>
          <p>For the parametric models, simple linear (<italic>df</italic>=4) and linear quadratic (<italic>df</italic>=5) mixed models were fitted, both using time and in addition the latter using time squared as fixed effects. As the third parametric model, we considered bounded growth mixed models (<italic>df</italic>=6) using the following formula:</p>
          <p>
            <disp-formula>y<sub>(</sub><italic><sub>t</sub></italic><sub>)</sub> = boundary + (y<sub>0</sub> - boundary) <italic>e<sup>-ct</sup></italic> <bold>(1)</bold></disp-formula>
          </p>
          <p>We treated boundary and baseline (y<sub>0</sub>) as random effects, while we considered the growth constant <italic>c</italic> as a fixed effect.</p>
        </sec>
        <sec>
          <title>Sensitivity Analyses</title>
          <p>In addition to our main analysis on practice effects as a function of repetition with the selection criteria of a minimum of 5 weeks and 5 repetitions, we performed 3 additional sensitivity analyses: sensitivity analyses 1 and 3 were modeling practice effects as a function of weeks since the first test instead of the number of repetitions, and sensitivity analyses 2 and 3 were performed using stricter selection criteria of a minimum of 10 weeks and 10 repetitions (<xref ref-type="table" rid="table1">Table 1</xref>).</p>
          <table-wrap position="float" id="table1">
            <label>Table 1</label>
            <caption>
              <p>Comparison of the main analysis with the 3 sensitivity analyses performed.</p>
            </caption>
            <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
              <col width="390"/>
              <col width="300"/>
              <col width="310"/>
              <thead>
                <tr valign="top">
                  <td>Criteria</td>
                  <td>Minimum of 5 weeks and 5 repetitions</td>
                  <td>Minimum of 10 weeks and 10 repetitions</td>
                </tr>
              </thead>
              <tbody>
                <tr valign="top">
                  <td>Practice effects as a function of number of repetitions</td>
                  <td>Main analysis</td>
                  <td>Sensitivity analysis 2</td>
                </tr>
                <tr valign="top">
                  <td>Practice effects as a function of weeks since first test</td>
                  <td>Sensitivity analysis 1</td>
                  <td>Sensitivity analysis 3</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p>All statistical analyses were performed using R 4.0.3 (R Foundation for Statistical Computing). Point estimates are accompanied by 95% CI in brackets, unless otherwise stated. <italic>P</italic> values were based on two-tailed <italic>t</italic> tests, unadjusted unless otherwise stated and considered significant if &#60;.05. All analysis codes can be found on the web [<xref ref-type="bibr" rid="ref27">27</xref>]. The data set used can be found on the web [<xref ref-type="bibr" rid="ref28">28</xref>].</p>
        </sec>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Overview</title>
        <p>Of the 1147 patients who performed at least one cognitive <italic>e-SDMT</italic>, 262 (22.8%) fulfilled our selection criteria of a minimum of 5 repetitions and 5 weeks between the first and last repetitions, accounting for 77.31% (4824/6240) of all performed <italic>e-SDMT</italic> tests. For <italic>Finger Pinching</italic> and <italic>Draw a Shape</italic>, 23.8% (264/1109) and 24% (259/1079) patients were selected, accounting for 87.14% (19,650/22,550) and 87.18% (19,019/21,816) of the performed tests, respectively. For <italic>Two Minute Walk</italic>, <italic>U-Turn,</italic> and <italic>Static Balance</italic>, 29.7% (171/575), 24.1% (217/901), and 24.34% (257/1056) patients were selected, representing 92.79% (14,393/15,512), 89.37% (15,051/16,841), and 88.41% (16,797/19,000) of the respective tests (<xref ref-type="table" rid="table2">Table 2</xref>). The minimum intertest interval was constrained by the app to 7 days for <italic>e-SDMT</italic>, 2 days for <italic>Finger Pinching</italic> and <italic>Draw a Shape</italic> for each hand, and 1 day for <italic>Two Minute Walk</italic>, <italic>U-Turn, and Static Balance</italic>, explaining the lower number of <italic>e</italic>-<italic>SDMT</italic> repetitions. However, participants had highly variable intertest intervals, making this an irregular time series, as indicated by each participant’s median intertest interval and IQR. <xref ref-type="table" rid="table2">Table 2</xref> shows the median of these statistics for all the selected participants.</p>
        <table-wrap position="float" id="table2">
          <label>Table 2</label>
          <caption>
            <p>Characteristics of included patients with multiple sclerosis.</p>
          </caption>
          <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
            <col width="30"/>
            <col width="190"/>
            <col width="130"/>
            <col width="130"/>
            <col width="130"/>
            <col width="0"/>
            <col width="130"/>
            <col width="130"/>
            <col width="130"/>
            <thead>
              <tr valign="top">
                <td colspan="2">Domain</td>
                <td>Cognition</td>
                <td colspan="3">Dexterity</td>
                <td colspan="3">Mobility</td>
              </tr>
              <tr valign="top">
                <td colspan="2">
                  <break/>
                </td>
                <td>
                  <italic>Electronic Symbol Digit Modalities Test</italic>
                </td>
                <td>
                  <italic>Finger Pinching</italic>
                </td>
                <td>
                  <italic>Draw a Shape</italic>
                </td>
                <td colspan="2">
                  <italic>Two Minute Walk</italic>
                </td>
                <td>
                  <italic>U-Turn</italic>
                </td>
                <td>
                  <italic>Static Balance</italic>
                </td>
              </tr>
            </thead>
            <tbody>
              <tr valign="top">
                <td colspan="9">
                  <bold>Number of patients meeting selection criteria</bold>
                </td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Total, N</td>
                <td>1147</td>
                <td>1109<sup>a</sup></td>
                <td>1079<sup>b</sup></td>
                <td colspan="2">575</td>
                <td>901</td>
                <td>1056</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Selected, n (%)</td>
                <td>262 (22.8)</td>
                <td>264 (23.8)</td>
                <td>259 (24)</td>
                <td colspan="2">171 (29.7)</td>
                <td>217 (24.1)</td>
                <td>257 (24.3)</td>
              </tr>
              <tr valign="top">
                <td colspan="9">
                  <bold>Number of tests performed by these patients</bold>
                </td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Total, N</td>
                <td>6240</td>
                <td>22,550</td>
                <td>21,816</td>
                <td colspan="2">15,512</td>
                <td>16,841</td>
                <td>19,000</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Selected, n (%)</td>
                <td>4824 (77.3)</td>
                <td>19,650 (87.1)</td>
                <td>19,019 (87.2)</td>
                <td colspan="2">14,393 (92.8)</td>
                <td>15,051 (89.4)</td>
                <td>16,797 (88.4)</td>
              </tr>
              <tr valign="top">
                <td colspan="9">
                  <bold>Sex</bold>
                </td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Total, N</td>
                <td>262</td>
                <td>499</td>
                <td>484</td>
                <td colspan="2">171</td>
                <td>217</td>
                <td>257</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Female, n (%)</td>
                <td>184 (70.2)</td>
                <td>353 (70.7)</td>
                <td>345 (71.3)</td>
                <td colspan="2">123 (71.9)</td>
                <td>155 (71.4)</td>
                <td>181 (70.4)</td>
              </tr>
              <tr valign="top">
                <td colspan="2">Age (years), median (IQR; range)</td>
                <td>50.2 (42.0-58.0; 20.0-79.0)</td>
                <td>50.0 (41.8-58.0; 20.0-79.0)</td>
                <td>49.6 (41.5-58.0; 20.0-79.0)</td>
                <td colspan="2">50.0 (41.6-58.1; 20.0-74.5)</td>
                <td>49.6 (41.5-57.0; 20.0-79.0)</td>
                <td>48.7 (41.1-57.0; 20.0-79.0)</td>
              </tr>
              <tr valign="top">
                <td colspan="2">Number of repetitions, median (IQR; range)</td>
                <td>11 (7-18; 5-119)</td>
                <td>17 (9-41.5; 5-416)</td>
                <td>17 (9-41; 5-414)</td>
                <td colspan="2">30 (15-83.5; 5-827)</td>
                <td>24 (11-69; 5-829)</td>
                <td>24 (12-67; 5-828)</td>
              </tr>
              <tr valign="top">
                <td colspan="2">Median of intertest intervals (days), median (IQR; range)</td>
                <td>7.9 (7.1-10.2; 6.7-87.1)</td>
                <td>3.1 (2.1-5.4; 1.9-42.8)</td>
                <td>3.3 (2.2-5.6; 1.9-77.6)</td>
                <td colspan="2">1.4 (1.0-3.0; 1.0-24.9)</td>
                <td>1.8 (1.1-3.3; 1.0-25.4)</td>
                <td>1.7 (1.1-3.1; 0.7-28.4)</td>
              </tr>
              <tr valign="top">
                <td colspan="2">Median of IQR of intertest intervals (days), median (IQR; range)</td>
                <td>3.6 (1.0-9.9; 0.0-133.8)</td>
                <td>3.3 (1.1-8.0; 0.0-198.1)</td>
                <td>3.4 (1.1-8.8; 0.0-251.0)</td>
                <td colspan="2">2.0 (0.9-5.1; 0.1-39.2)</td>
                <td>2.6 (0.9-6.9; 0.0-81.5)</td>
                <td>2.3 (0.8-7.7; 0.0-93.0)</td>
              </tr>
              <tr valign="top">
                <td colspan="2">Number of weeks from the first to the last test, median (IQR; range)</td>
                <td>18.3 (11.5-54.1; 5.0-164.7)</td>
                <td>17.4 (10.9-49.4; 5.0-164.7)</td>
                <td>17.9 (11.0-49.9; 5.0-164.7)</td>
                <td colspan="2">17.2 (11.1-48.2; 5.0-146.3)</td>
                <td>16.3 (10.3-47.0; 5.0-146.3)</td>
                <td>16.7 (10.3-47.0; 5.0-152.1)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="table2fn1">
              <p><sup>a</sup>With 26.19% (499/1905) of hands selected.</p>
            </fn>
            <fn id="table2fn2">
              <p><sup>b</sup>With 26.23% (484/1845) of hands selected.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Cognition: e-SDMT</title>
        <p>A summary analysis of the 262 selected patients yielded a mean difference from the first to last score of 9.8 correct responses, representing an average observed improvement of 25.4% (95% CI 23.1% to 27.8%) from the first score. Although the majority of this improvement (19.7%, 95% CI 17.5% to 21.9%) occurred up to the fifth score and can thus be considered a short-term learning effect, there was still a significant improvement from the fifth score onward of, on average, 5.7% (95% CI 4.1% to 7.4%), suggesting a long-term practice effect. A multivariate regression model of this difference yielded a significant association with the total number of repetitions, further supporting the long-term practice effects (<xref rid="figure1" ref-type="fig">Figure 1</xref>). Age was positively correlated with the number of repetitions performed (Pearson correlation coefficient, <italic>R</italic>=0.19; <italic>P</italic>=.003), but the first score was not (<italic>R</italic>=−0.03; <italic>P</italic>=.70; <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>).</p>
        <fig id="figure1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Patient-level summary analysis for the <italic>electronic Symbol Digit Modalities Test</italic>: comparison of the first, fifth, and last score. Multivariate association of the difference from the fifth to last score with age, first and fifth score, and the log-transformed number of repetitions (n=262 patients). <italic>e-SDMT</italic>: <italic>electronic Symbol Digit Modalities Test</italic>.</p>
          </caption>
          <graphic xlink:href="jmir_v23i11e30394_fig1.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
        <p>When comparing performances by 5th, 25th, 50th, 75th, and 95th percentile groups up to the fifth trial with quantile regression, baseline performances were normally distributed with intercept estimates of 22.0 (19.1-24.9), 34.0 (32.7-35.3), 40.0 (38.8-41.2), 46.3 (45.1-47.6), and 55.0 (53.4-56.6), respectively. The ANOVA-type test for all 5 slopes (β=1.5-2.0) did not suggest that short-term learning rates for these groups differed significantly (<italic>P</italic>=.80; <xref rid="figure2" ref-type="fig">Figure 2</xref>).</p>
        <fig id="figure2" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Linear quantile regression for the <italic>electronic Symbol Digit Modalities Test</italic> of short-term learning effects up to the fifth repetition. Comparison of baseline performance and linear slope of low (5th and 25th percentiles), median, and high performers (75th and 95th percentiles). Quantile regression <italic>P</italic> values are Bonferroni-adjusted (n=1310 tests). ANOVA: analysis of variance; <italic>e-SDMT</italic>: <italic>electronic Symbol Digit Modalities Test</italic>.</p>
          </caption>
          <graphic xlink:href="jmir_v23i11e30394_fig2.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
        <p>The long-term learning curve analysis showed that the bounded growth model fit the data best with an RMSE of 3.3 correct responses, followed by 3.6 for the smoothing spline, 3.8 for the quadratic, and 4.0 for the linear model (<xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref>). Strong boundary practice effects were found with baseline estimates of on average 41.0 (95% CI 39.8 to 42.2) correct responses and boundary estimates of 57.7 (95% CI 55.7 to 59.8) correct responses, leading to an average improvement over baseline of 40.8% (95% CI 39.9% to 41.6%). Half of the practice effect was reached after 11 repetitions and 90% after 35 repetitions (<xref rid="figure3" ref-type="fig">Figure 3</xref>).</p>
        <fig id="figure3" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Learning curve analysis for the <italic>electronic Symbol Digit Modalities Test</italic>: bounded growth mixed model of practice effects with 95% CI band and baseline, 50% and 90% practice points marked (m=slope of tangent; n=4824 tests). <italic>e-SDMT</italic>: <italic>electronic Symbol Digit Modalities Test</italic>.</p>
          </caption>
          <graphic xlink:href="jmir_v23i11e30394_fig3.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
        <p>For <italic>e-SDMT</italic> corrected for dexterity and reaction speed, Spearman correlation of all 6190 corrected scores with their uncorrected counterpart yielded ρ=0.55. The resulting practice effects were very similar to the uncorrected <italic>e-SDMT</italic>, with an observed improvement from the first to last score of 19% (95% CI 16.1% to 22%), consisting of 12.4% (95% CI 9.8% to 15%) from the first to fifth score, and 6.6% (95% CI 4.6% to 8.7%) from the fifth to last score. As with the uncorrected <italic>e-SDMT</italic>, no significant differences in short-term learning rates were found between low, median, and high performers (ANOVA-type <italic>P</italic>=.30). Boundary long-term improvements were 23.5% (95% CI 23% to 24%), with half of the practice effect reached after 7 repetitions and 90% practice effect reached after 23 repetitions (<xref ref-type="supplementary-material" rid="app3">Multimedia Appendices 3</xref>-<xref ref-type="supplementary-material" rid="app6">6</xref>).</p>
      </sec>
      <sec>
        <title>Dexterity: Finger Pinching</title>
        <p>A summary analysis of the 499 selected hands yielded a mean difference from the first to last score of 14.3 successful pinches, representing an average observed improvement of 54.2% (95% CI 49.3% to 59.1%) over the first score. Similar to the findings on the <italic>e-SDMT</italic>, the majority of this improvement (31.5%, 95% CI 27.5% to 35.4%) occurred up to the fifth score, compatible with a short-term learning effect. However, the remaining improvement of 22.7% (95% CI 18.6% to 26.8%) occurred after the fifth trial. This improvement was significantly associated with the total number of repetitions, indicating a strong long-term practice effect (<xref rid="figure4" ref-type="fig">Figure 4</xref>). Age was positively correlated with the number of repetitions performed (<italic>R</italic>=0.21; <italic>P</italic>&#60;.001) but the first score was not (<italic>R</italic>=−0.06; <italic>P</italic>=.20; <xref ref-type="supplementary-material" rid="app7">Multimedia Appendix 7</xref>).</p>
        <fig id="figure4" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Hand-level summary analysis for <italic>Finger Pinching</italic>: comparison of the first, fifth, and last score. Multivariate association of the difference from the fifth to last score with age, first and fifth score, and the log-transformed number of repetitions (n=499 hands).</p>
          </caption>
          <graphic xlink:href="jmir_v23i11e30394_fig4.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
        <p>Baseline performances were normally distributed with intercept estimates of 6.0 (95% CI 4.5 to 7.5) for the fifth percentile, 19.0 (95% CI 17.8 to 20.2) for the 25th, 27.0 (95% CI 25.8 to 28.2) for median performers, 37.0 (95% CI 35.6 to 38.4) for the 75th, and 51.7 (95% CI 49.6 to 53.8) for the 95th percentile with quantile regression. The β coefficients for short-term learning up to the fifth trial were the highest for the 75th percentile and median performers with 2.50 (95% CI 1.96 to 3.04) and 2.00 (95% CI 1.45 to 2.55) additional successful pinches per repetition, lower for the 25th percentile (1.50, 95% CI 1.00 to 2.00) and the lowest for the 5th and 95th percentiles (1.25, 95% CI 0.57 to 1.93, and 1.33, 95% CI 0.56 to 2.11, respectively). These differences in slopes between performance levels were significant (ANOVA-type <italic>P</italic>&#60;.001; <xref rid="figure5" ref-type="fig">Figure 5</xref>).</p>
        <fig id="figure5" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Linear quantile regression for <italic>Finger Pinching</italic> of short-term learning effects up to the fifth repetition. Comparison of baseline performance and linear slope of low (5th and 25th percentiles), median, and high performers (75th and 95th percentiles). Quantile regression <italic>P</italic> values are Bonferroni-adjusted (n=2495 tests). ANOVA: analysis of variance.</p>
          </caption>
          <graphic xlink:href="jmir_v23i11e30394_fig5.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
        <p>Long-term learning curve analysis again showed that the bounded growth model fit the data best with an RMSE of 6.8 successful pinches, followed by 7.5 for the smoothing spline, 7.9 for the quadratic, and 8.1 for the linear model (<xref ref-type="supplementary-material" rid="app8">Multimedia Appendix 8</xref>). Strong boundary practice effects were found with baseline estimates of, on average, 31.4 (95% CI 30.2 to 32.5) and boundary estimates of 58.4 (95% CI 55.5 to 61.4) successful pinches, leading to an average improvement over baseline of 86.2% (95% CI 83.6% to 88.7%). Half of the practice effect was reached after 28 repetitions and 90% after 94 repetitions (<xref rid="figure6" ref-type="fig">Figure 6</xref>).</p>
        <fig id="figure6" position="float">
          <label>Figure 6</label>
          <caption>
            <p>Learning curve analysis for <italic>Finger Pinching</italic>: bounded growth mixed model of practice effects with 95% CI band and baseline, 50%, and 90% practice points marked (m=slope of tangent; n=19,650 tests).</p>
          </caption>
          <graphic xlink:href="jmir_v23i11e30394_fig6.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
      </sec>
      <sec>
        <title>Dexterity: Draw a Shape</title>
        <p>A summary analysis of the 484 selected hands yielded a mean improvement in the number of shapes drawn correctly from the first to last score of 23.9% (95% CI 18.3% to 29.5%), from the first to fifth score of 15.1% (95% CI 9.8% to 20.3%), and from the fifth to last score of 8.8% (95% CI 3.8% to 13.8%). This difference was significantly associated with the total number of repetitions, suggesting a long-term practice effect (<xref rid="figure7" ref-type="fig">Figure 7</xref>). Age was positively correlated with the number of repetitions performed (<italic>R</italic>=0.22; <italic>P</italic>&#60;.001) but the first score was not (<italic>R</italic>=−0.08; <italic>P</italic>=.09; <xref ref-type="supplementary-material" rid="app9">Multimedia Appendix 9</xref>).</p>
        <fig id="figure7" position="float">
          <label>Figure 7</label>
          <caption>
            <p>Hand-level summary analysis for <italic>Draw a Shape</italic>: comparison of the first, fifth, and last score. Multivariate association of the difference from the fifth to the last score with age, first and fifth score, and the log-transformed number of repetitions (n=484 hands).</p>
          </caption>
          <graphic xlink:href="jmir_v23i11e30394_fig7.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
        <p>Intercept estimates for baseline performances were 1 shape drawn correctly for the 5th percentile, 2 for the 25th percentile, 3 for the median performers, 5 for the 75th percentile, and 6 for the 95th percentile with quantile regression. In this analysis, only median performers showed a significant short-term learning rate up to the fifth trial (<xref ref-type="supplementary-material" rid="app10">Multimedia Appendix 10</xref>).</p>
        <p>The long-term learning curve analysis again showed that bounded growth models fit the data best with an RMSE of 1.02 shape drawn correctly, followed by 1.06 for the smoothing spline, 1.07 for the quadratic, and 1.08 for the linear model (<xref ref-type="supplementary-material" rid="app11">Multimedia Appendix 11</xref>). Boundary practice effects were found with an average improvement over baseline of 23.1% (95% CI 20.9% to 25.2%), reaching half of the practice effect after 17 repetitions and 90% after 56 repetitions (<xref rid="figure8" ref-type="fig">Figure 8</xref>).</p>
        <fig id="figure8" position="float">
          <label>Figure 8</label>
          <caption>
            <p>Learning curve analysis for <italic>Draw a Shape</italic>: bounded growth mixed model of practice effects with 95% CI band and baseline, 50%, and 90% practice points marked (m=slope of tangent; n=19,019 tests).</p>
          </caption>
          <graphic xlink:href="jmir_v23i11e30394_fig8.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
      </sec>
      <sec>
        <title>Mobility: Two Minute Walk</title>
        <p>A summary analysis of the 171 selected patients yielded no significant difference between the first, fifth, and last scores with a mean difference from the fifth to last score of 1.4 (95% CI −5.2 to 7.9) steps. This difference was also not associated with the total number of repetitions performed (<xref rid="figure9" ref-type="fig">Figure 9</xref> and <xref ref-type="supplementary-material" rid="app12">Multimedia Appendix 12</xref>).</p>
        <fig id="figure9" position="float">
          <label>Figure 9</label>
          <caption>
            <p>Patient-level summary analysis for <italic>Two Minute Walk</italic>: comparison of the first, fifth, and last score. Multivariate association of the difference from the fifth to the last score with age, first and fifth score, and the log-transformed number of repetitions (n=171 patients).</p>
          </caption>
          <graphic xlink:href="jmir_v23i11e30394_fig9.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
        <p>The distribution of baseline performance was left-skewed with performers in the 5th percentile achieving, on average, 87.0 (95% CI 52.2 to 121.8) steps; in the 25th percentile, 181.0 (95% CI 170.7 to 191.3) steps; on median, 219.0 (95% CI 212.6 to 225.4) steps; in the 75th percentile, 236.0 (95% CI 230.6 to 241.4) steps; and in the 95th percentile, 260.0 (95% CI 255.2 to 264.8) steps. No significant slopes up to the fifth trial could be observed (<xref ref-type="supplementary-material" rid="app13">Multimedia Appendix 13</xref>).</p>
      </sec>
      <sec>
        <title>Mobility: U-Turn</title>
        <p>A summary analysis of the 217 selected patients yielded a significant improvement from the first to last score with a mean difference in turn speed average of 0.13 rad/s, representing an average observed difference of 11.0% (95% CI 5.7% to 16.2%) over the first score. However, the majority of this difference occurred up to the fifth score (9%, 95% CI 3.7% to 14.3%), and the remaining difference from the fifth to last score (1.9%, 95% CI −2.3% to 6.1%) was neither significant nor associated with the total number of repetitions performed (<xref rid="figure10" ref-type="fig">Figure 10</xref> and <xref ref-type="supplementary-material" rid="app14">Multimedia Appendix 14</xref>).</p>
        <fig id="figure10" position="float">
          <label>Figure 10</label>
          <caption>
            <p>Patient-level summary analysis for <italic>U-Turn</italic>: comparison of the first, fifth, and last score. Multivariate association of the difference from the fifth to the last score with age, first and fifth score, and the log-transformed number of repetitions (n=217 patients).</p>
          </caption>
          <graphic xlink:href="jmir_v23i11e30394_fig10.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
        <p>Baseline performances estimated with quantile regression were normally distributed with 0.5 rad/s (95% CI 0.5 to 0.6) for the 5th percentile, 0.9 rad/s (95% CI 0.9 to 1.0) for the 25th percentile, 1.3 rad/s (95% CI 1.2 to 1.3) for median performers, 1.5 rad/s (95% CI 1.5 to 1.6) for the 75th percentile, and 2.0 rad/s (95% CI 1.9 to 2.1) for the 95th percentile groups. Only the slope of the 25th percentile group was significant in this analysis up to the fifth trial (β=.04; 95% CI 0.02 to 0.06), and the difference in slopes was not significant in the ANOVA-type test (<italic>P</italic>=.40; <xref ref-type="supplementary-material" rid="app15">Multimedia Appendix 15</xref>).</p>
      </sec>
      <sec>
        <title>Mobility: Static Balance</title>
        <p>A summary analysis of the 257 selected patients yielded a significant difference from the first to last score, with a mean difference in sway path of −16.9 m/s². This is the only test in which fewer numbers are better. Thus, the average observed improvement was −28.6% (95% CI −48.6% to −8.5%) over the first score. However, the majority of this improvement occurred up to the fifth score (−21.1%, 95% CI −45% to −2.8%), and the remaining difference from the fifth to last score (−7.5%, 95% CI −24.1% to 9.2%) was neither significant nor associated with the total number of repetitions performed (<xref rid="figure11" ref-type="fig">Figure 11</xref> and <xref ref-type="supplementary-material" rid="app16">Multimedia Appendix 16</xref>).</p>
        <fig id="figure11" position="float">
          <label>Figure 11</label>
          <caption>
            <p>Patient-level summary analysis for <italic>Static Balance</italic>: comparison of the first, fifth, and last score. Multivariate association of the difference from the fifth to the last score with age, first and fifth score, and the log-transformed number of repetitions (n=257 patients).</p>
          </caption>
          <graphic xlink:href="jmir_v23i11e30394_fig11.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
        <p>Baseline performance estimates were strongly right-skewed with 5.7 m/s² (95% CI 4.3 to 7.0) for the 5th percentile, 11.7 m/s² (95% CI 9.4 to 14.0) for the 25th percentile, 23.8 m/s² (95% CI 20.7 to 26.8) for the median performers, 68.0 m/s² (95% CI 55.7 to 80.3) for the 75th percentile, and 260.2 m/s² (95% CI 200.4 to 320.0) for the 95th percentile. In this test, the 5th and 25th percentiles are the top performing groups, and their quantile regression slopes up to the fifth trial are not significant. However, the significant negative slopes of median (β=−2.32; 95% CI −3.47 to −1.17), 75th percentile (β=−8.46; 95% CI −12.21 to −4.72), and 95th percentile (β=−27.25; 95% CI −46.30 to −8.20) performers were increasingly steep, and the overall ANOVA-type difference test yielded <italic>P</italic>&#60;.001(<xref ref-type="supplementary-material" rid="app17">Multimedia Appendix 17</xref>).</p>
      </sec>
      <sec>
        <title>Sensitivity Analyses</title>
        <p>The results of the sensitivity analyses were in line with the results of the main analysis. Sensitivity analysis 2, which used stricter inclusion criteria with a minimum of 10 weeks and 10 repetitions, was overall very similar with expected further increases in mean improvement from the fifth to last score (mean improvement 5.7% for main analysis vs 9.1% for sensitivity analysis 2 for <italic>e-SDMT</italic>; 22.7% for main analysis vs 35.0% for sensitivity analysis 2 for <italic>Finger Pinching</italic>; and 8.8% for main analysis vs 13.3% for sensitivity analysis 2 for <italic>Draw a Shape</italic>) and a slight decrease in average boundary increase in performance (average boundary increase 40.8% for main analysis vs 34.3% for sensitivity analysis 2 for <italic>e-SDMT</italic>; 86.2% for main analysis vs 73.8% for sensitivity analysis 2 for <italic>Finger Pinching</italic>; and 23.1% for main analysis vs 19.8% for sensitivity analysis 2 for <italic>Draw a Shape</italic>). Sensitivity analyses 1 and 3, which modeled practice effects as a function of weeks since the first test instead of the number of repetitions, also supported the main findings. However, the association of the maximum number of weeks from the first to the last tests with the difference from the fifth to last score was generally lower and so was the average increase in performance (<xref ref-type="supplementary-material" rid="app18">Multimedia Appendix 18</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <sec>
        <title>Principal Findings</title>
        <p>Strong long-term practice effects were found for <italic>e-SDMT</italic>, <italic>Finger Pinching</italic>, and <italic>Draw a Shape</italic>, with mean observed improvements of 25.4%, 54.2%, and 23.9% from the first to last score, respectively. Of these, 5.7%, 22.7%, and 8.8% occurred from the fifth score onward. However, the number of repetitions differed widely among participants with a range of 5-119 repetitions for <italic>e-SDMT</italic> (median 11), 5-416 for <italic>Finger Pinching</italic> (median 17), and 5-414 for <italic>Draw a Shape</italic> (median 17), introducing bias. To estimate boundary practice effects independent of the number of repetitions in our sample, we modeled learning curves with bounded growth models, a subtype of nonlinear mixed models. This approach yielded boundary improvements over the baseline of 40.8% for <italic>e-SDMT</italic>, 86.2% for <italic>Finger Pinching</italic>, and 23.1% for <italic>Draw a Shape</italic>. Interestingly, the practice effect seemed to last longer for the dexterity tests <italic>Finger Pinching</italic> and <italic>Draw a Shape</italic>, reaching half of the practice effect after repetition 28 and 17, respectively, compared to repetition 11 for <italic>e-SDMT</italic>.</p>
        <p>These practice effects likely include both short-term learning effects, where patients become acquainted with the tests, and long-term practice effects. We believe these effects have not only different origins, time scales, and magnitudes but also different implications for the use of digital assessments in clinical studies and clinical practice. Short-term learning effects can be addressed by ensuring that participants have sufficient training before the observational period; long-term practice effects constitute a significant challenge for all applications beyond trials with a comparator arm. Although these effects are impossible to untangle in an unsupervised setting like this, we considered improvements up to the fifth trial to be more likely due to short-term learning and improvements afterward more likely because of long-term practice effects, based on the recommendation to use the fifth trial of the 9HPT as baseline [<xref ref-type="bibr" rid="ref24">24</xref>].</p>
        <p>For <italic>U-Turn</italic> and <italic>Static Balance</italic>, only short-term learning effects could be observed, ceasing after a maximum of 5 repetitions. Interestingly, for <italic>Static Balance</italic>, these short-term learning effects were not present in those with high baseline performance and were most pronounced in those with low baseline performance, potentially highlighting that the test instructions were not clear from the beginning. For <italic>Two Minute Walk</italic>, neither short-term learning nor long-term practice effects were observed.</p>
        <p>For <italic>e-SDMT</italic>, quantile regression analysis suggested that the short-term learning rate was independent of the baseline performance. However, for <italic>Finger Pinching</italic>, median and high performers improved significantly faster than low and highest performers, with the learning rate decreasing toward the extremes. One can hypothesize that low performers might be more physically disabled, preventing them from improving as quickly as the median performers. On the other hand, the highest performers might reach their boundary sooner, leaving less room for improvement.</p>
        <p>The 3 sensitivity analyses confirmed our main findings. However, for sensitivity analyses 1 and 3, which modeled practice effects as a function of weeks since the first test instead of the number of repetitions, the effect sizes were smaller. We believe this is caused by the irregular nature of these time-series data, as the intertest intervals differed widely, highlighting a complication in user-scheduled testing (<xref ref-type="table" rid="table2">Table 2</xref>).</p>
      </sec>
      <sec>
        <title>Comparison With Previous Work</title>
        <sec>
          <title>Overview</title>
          <p>Only a few studies have examined practice effects in smartphone-based tests for patients with MS. Bove et al [<xref ref-type="bibr" rid="ref14">14</xref>] analyzed the data from 38 patients, 22 of whom completed the planned study period of 12 months. They found strong practice effects for both their custom-made cognitive tests (digital adaptations of the trail-making test, the n-back test, a verbal fluency test, and an attention test), and a digital adaptation of the 9HPT. Interestingly, they suggest using person-specific learning curves quantified by binary spline inflection point analysis as a potential outcome measure [<xref ref-type="bibr" rid="ref14">14</xref>].</p>
          <p>In addition, Liao et al [<xref ref-type="bibr" rid="ref29">29</xref>] recently reported significant practice effects for information processing speed and manual dexterity but not for walking speed in a tablet-based test battery called <italic>MS Performance Test</italic>, broadly confirming our results. However, they only analyzed 2-5 repetitions per patient and per test and could thus not examine long-term practice effects. Interestingly, they found that younger age was associated with larger practice effects, whereas we observed the opposite for <italic>e-SDMT</italic> and <italic>Finger Pinching</italic> (<xref ref-type="supplementary-material" rid="app1">Multimedia Appendices 1</xref> and <xref ref-type="supplementary-material" rid="app7">7</xref>), potentially highlighting differences between their low-frequency and our high-frequency testing.</p>
        </sec>
        <sec>
          <title>Cognition: SDMT</title>
          <p>Practice effects are well known for SDMT in both healthy controls and patients with MS, although the effect sizes reported were highly variable. Morrow et al [<xref ref-type="bibr" rid="ref30">30</xref>] studied 660 natalizumab-treated patients with MS with a total of 13 repetitions of the oral SDMT over 48 weeks with average baseline scores of 46.8 (SD 15.3) correct responses and average final scores of 62.2 (SD 18.1) at week 48, resulting in an average improvement of 32.9% over baseline. Although the improvement was most pronounced over the first 3 repetitions, there was no obvious boundary [<xref ref-type="bibr" rid="ref30">30</xref>].</p>
          <p>In contrast, Benedict et al [<xref ref-type="bibr" rid="ref31">31</xref>] found only minimal practice effects in 76 patients with MS with a total of 6 repetitions of oral SDMT over 5 months. Average baseline scores of 49.8 (SD 12.4) correct responses and average final scores of 52.5 (SD 14.3) at month 5, representing an improvement of only 5.4% over baseline, were found. However, their 25 healthy controls improved from 62.0 (SD 11.3) to 71.4 (SD 13.2), representing a practice effect of 15.1% [<xref ref-type="bibr" rid="ref31">31</xref>].</p>
          <p>Roar et al [<xref ref-type="bibr" rid="ref32">32</xref>] examined practice effects in 80 natalizumab-treated patients with MS with up to 31 repetitions over 30 months and reported improvements of roughly 25% over baseline, on average, with the rate of improvement slowing down after 6 months. Baseline performance and relative improvement were worse for the more severely affected patients with MS [<xref ref-type="bibr" rid="ref32">32</xref>]. Interestingly, rearrangement of the SDMT symbol key resulted in a return to baseline performance, suggesting that the practice effect could be attributed to key memorization and that no generalizable learning or improvement of processing speed occurred [<xref ref-type="bibr" rid="ref32">32</xref>].</p>
          <p>Indeed, all of the traditional paper and pencil SDMT versions have the limitation of a fixed key, which is why Benedict et al [<xref ref-type="bibr" rid="ref33">33</xref>] recommend the use of equivalent forms with alternate keys to mitigate practice effects. The smartphone-based <italic>e-SDMT</italic> version examined in this study has changing keys, thus emulating the process of alternate forms. Key changes are not truly random, and the subtlety of the original SDMT, in which the first 26 items only use the first 6 symbols in the key, is preserved [<xref ref-type="bibr" rid="ref34">34</xref>].</p>
          <p>With our result of an average boundary improvement over baseline of 40.8%, we can show that with weekly testing, practice effects for SDMT are likely to be stronger than with monthly testing, as performed by the abovementioned studies, and at least partly independent of the key.</p>
          <p>As a limitation, the smartphone-based test in this study was not oral but based on touching a number pad, potentially biasing the results by dexterity problems (and dexterous practice effects). However, our analysis of <italic>e-SDMT</italic> corrected for dexterity and reaction speed by using Floodlight’s <italic>baseline</italic> showed very similar results, suggesting that this is not a major issue, potentially because patients are free to use their preferred hand for this test.</p>
        </sec>
        <sec>
          <title>Dexterity: 9HPT</title>
          <p>Practice effects often become apparent in the examination of test-retest, intrarater, and interrater reliability. In this way, Cohen et al [<xref ref-type="bibr" rid="ref35">35</xref>] found evident practice effects for the 9HPT first in 10 and later in 436 secondary progressive patients with MS over 4-6 repetitions in up to 4 weeks, which stabilized after 3 repetitions [<xref ref-type="bibr" rid="ref21">21</xref>].</p>
          <p>Solari et al [<xref ref-type="bibr" rid="ref24">24</xref>] found even stronger practice effects in 32 patients with MS with 6 repetitions in 24 hours, which stabilized after 4 repetitions. As a consequence, they recommend performing 9HPT 4 times before baseline in any study to mitigate practice effects [<xref ref-type="bibr" rid="ref24">24</xref>].</p>
          <p>The smartphone-based <italic>Finger Pinching</italic> and, to a slightly lesser extent, also the <italic>Draw a Shape</italic> tests we examined seem to have much stronger and longer-lasting practice effects than the 9HPT. It can be speculated that high-frequency testing (ie, sustained daily practice over multiple months) maximizes the long-term practice effect.</p>
        </sec>
        <sec>
          <title>Mobility: T25FW</title>
          <p>No practice effects were found for T25FW, which was examined alongside 9HPT in the abovementioned studies [<xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref35">35</xref>]. This result is in line with our finding of no long-term practice effect in the smartphone-based mobility tests, <italic>Two Minute Walk</italic> and <italic>U-Turn</italic>, which have been validated with the T25FW [<xref ref-type="bibr" rid="ref9">9</xref>]. However, the outcome reported for <italic>Two Minute Walk</italic> in this study (ie, number of steps) is a quantitative gait parameter and thus representative of endurance, unlike the more qualitative gait parameter <italic>step power</italic> used by Montalban et al [<xref ref-type="bibr" rid="ref9">9</xref>] for validation against T25FW.</p>
        </sec>
      </sec>
      <sec>
        <title>Limitations</title>
        <p>MS diagnoses of study participants were self-declared, and there was no confirmation or assessment by health professionals. In addition, no clinical information was available for the participants to compare with their performance in digital tests. Differences caused by disease duration, severity, or treatment could not be analyzed.</p>
        <p>In addition, we observed a high variability of results, which is most likely partly due to biomedical day-to-day fluctuations and partly due to circumstantial and technical noise, for example, caused by interrupted test performance or sensor error. However, it is impossible to determine these effects using the present data set.</p>
        <p>Finally, these time-series data are highly irregular and have strong right-skewness. Our models expect data missing at random. We found no evidence that baseline performance influenced adherence and the number of repetitions, but age was found to be a confounder for all domains. Interestingly, older people tended to perform more repetitions than younger people (<italic>R</italic>=0.19 for <italic>e-SDMT</italic>; <italic>R</italic>=0.21 for <italic>Finger Pinching</italic>; and <italic>R</italic>=0.22 for <italic>Draw a Shape</italic>; <xref ref-type="supplementary-material" rid="app1">Multimedia Appendices 1</xref>, <xref ref-type="supplementary-material" rid="app7">7</xref>, and <xref ref-type="supplementary-material" rid="app9">9</xref>). One can hypothesize that this is because older patients with MS tend to be more severely affected and thus might have higher intrinsic motivation. Another possible explanation is that younger people might have more competing time commitments, for example, because of their occupation or family. As age was associated with larger observed improvements from the fifth to last score for <italic>e-SDMT</italic> and <italic>Finger Pinching</italic> (both <italic>R</italic>=0.16; <xref ref-type="supplementary-material" rid="app1">Multimedia Appendices 1</xref> and <xref ref-type="supplementary-material" rid="app7">7</xref>), this confounder might lead to slight overestimation of the practice effects. However, in the multivariate models, age was not a significant confounder (<xref rid="figure1" ref-type="fig">Figures 1</xref> and <xref rid="figure4" ref-type="fig">4</xref>). Nevertheless, there might be unobserved confounders that differ between those participants who quit early and those who stayed engaged for a long time, which we aimed to mitigate by sensitivity analyses 2 and 3.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p>In summary, we analyzed the practice effects in 6 active smartphone-based tests for cognition, dexterity, and mobility performed at high frequencies. Smartphone-based tests promise to help monitor MS disease trajectories, and there are currently multiple initiatives in development [<xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref36">36</xref>-<xref ref-type="bibr" rid="ref39">39</xref>]. Our results suggest that strong long-term practice effects in cognitive and dexterity tests must be accounted for to identify possible disease-related changes in these domains, lasting for more than 35 repetitions for <italic>e-SDMT</italic>, 94 for <italic>Finger Pinching</italic>, and 56 for <italic>Draw a Shape</italic>. This is important for the interpretation of these tests in the context of personalized health and in studies with no comparator arm. On the other hand, the lack of long-term practice effects in mobility tests simplifies their interpretation, even though short-term learning effects might have to be considered.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
      <supplementary-material id="app1">
        <label>Multimedia Appendix 1</label>
        <p>Pairwise associations for the &#60;italic&#62;electronic Symbol Digit Modalities Test&#60;/italic&#62; of the mean age, first score, fifth score, log-transformed number of repetitions performed, last score, and the difference from the fifth to the last score and their respective histograms (n=262 patients).</p>
        <media xlink:href="jmir_v23i11e30394_app1.png" xlink:title="PNG File , 362 KB"/>
      </supplementary-material>
      <supplementary-material id="app2">
        <label>Multimedia Appendix 2</label>
        <p>Model selection for &#60;italic&#62;electronic Symbol Digit Modalities Test&#60;/italic&#62;: Comparison of 4 mixed models of increasing complexity (parametric linear, quadratic and bounded growth models and the non–parametric smoothing spline model) by root mean squared error (RMSE) and (effective) degrees of freedom (eDF) used.</p>
        <media xlink:href="jmir_v23i11e30394_app2.png" xlink:title="PNG File , 343 KB"/>
      </supplementary-material>
      <supplementary-material id="app3">
        <label>Multimedia Appendix 3</label>
        <p>Comparison of correct responses of the &#60;italic&#62;electronic Symbol Digit Modalities Test&#60;/italic&#62; (x-axis) and of the &#60;italic&#62;electronic Symbol Digit Modalities Test&#60;/italic&#62; divided by baseline (y-axis) to correct for dexterity and reaction speed (n=6190 tests).</p>
        <media xlink:href="jmir_v23i11e30394_app3.png" xlink:title="PNG File , 220 KB"/>
      </supplementary-material>
      <supplementary-material id="app4">
        <label>Multimedia Appendix 4</label>
        <p>Patient-level summary analysis for the &#60;italic&#62;electronic Symbol Digit Modalities Test&#60;/italic&#62; corrected for dexterity and reaction speed: comparison of the first, fifth, and last score. Multivariate association of the difference from the fifth to the last score with age, first and fifth score, and the log-transformed number of repetitions (n=262 patients).</p>
        <media xlink:href="jmir_v23i11e30394_app4.png" xlink:title="PNG File , 74 KB"/>
      </supplementary-material>
      <supplementary-material id="app5">
        <label>Multimedia Appendix 5</label>
        <p>Linear quantile regression for the &#60;italic&#62;electronic Symbol Digit Modalities Test&#60;/italic&#62; (corrected for dexterity and reaction speed) of short-term learning effects up to the fifth repetition. Comparison of baseline performance and linear slope of low (5th and 25th percentiles), median, and high performers (75th and 95th percentiles). Quantile regression &#60;italic&#62;P&#60;/italic&#62; values are Bonferroni-adjusted (n=1310 tests).</p>
        <media xlink:href="jmir_v23i11e30394_app5.png" xlink:title="PNG File , 268 KB"/>
      </supplementary-material>
      <supplementary-material id="app6">
        <label>Multimedia Appendix 6</label>
        <p>Learning curve analysis for the &#60;italic&#62;electronic Symbol Digit Modalities Test&#60;/italic&#62; corrected for dexterity and reaction speed: bounded growth mixed model of practice effects with 95% CI band and baseline, 50%, and 90% practice points marked (m=slope of tangent; n=4801 tests).</p>
        <media xlink:href="jmir_v23i11e30394_app6.png" xlink:title="PNG File , 375 KB"/>
      </supplementary-material>
      <supplementary-material id="app7">
        <label>Multimedia Appendix 7</label>
        <p>Pairwise associations for &#60;italic&#62;Finger Pinching&#60;/italic&#62; of the mean age, first score, fifth score, log-transformed number of repetitions performed, last score, and the difference from the fifth to the last score and their respective histograms (n=499 hands).</p>
        <media xlink:href="jmir_v23i11e30394_app7.png" xlink:title="PNG File , 460 KB"/>
      </supplementary-material>
      <supplementary-material id="app8">
        <label>Multimedia Appendix 8</label>
        <p>Model selection for &#60;italic&#62;Finger Pinching&#60;/italic&#62;: comparison of 4 mixed models of increasing complexity (parametric linear, quadratic and bounded growth models, and the nonparametric smoothing spline model) by root mean squared error and (effective) degrees of freedom used.</p>
        <media xlink:href="jmir_v23i11e30394_app8.png" xlink:title="PNG File , 329 KB"/>
      </supplementary-material>
      <supplementary-material id="app9">
        <label>Multimedia Appendix 9</label>
        <p>Pairwise associations for &#60;italic&#62;Draw a Shape&#60;/italic&#62; of the mean age, first score, fifth score, log-transformed number of repetitions performed, last score, and the difference from the fifth to the last score and their respective histograms (n=484 hands).</p>
        <media xlink:href="jmir_v23i11e30394_app9.png" xlink:title="PNG File , 325 KB"/>
      </supplementary-material>
      <supplementary-material id="app10">
        <label>Multimedia Appendix 10</label>
        <p>Linear quantile regression for &#60;italic&#62;Draw a Shape&#60;/italic&#62; of short-term learning effects up to the fifth repetition. Comparison of baseline performance and linear slope of low (5th and 25th percentiles), median, and high performers (75th and 95th percentiles). Quantile regression &#60;italic&#62;P&#60;/italic&#62; values are Bonferroni-adjusted (n=2420 tests).</p>
        <media xlink:href="jmir_v23i11e30394_app10.png" xlink:title="PNG File , 345 KB"/>
      </supplementary-material>
      <supplementary-material id="app11">
        <label>Multimedia Appendix 11</label>
        <p>Model selection for &#60;italic&#62;Draw a Shape&#60;/italic&#62;: comparison of 4 mixed models of increasing complexity (parametric linear, quadratic and bounded growth models, and the nonparametric smoothing spline model) by root mean squared error and (effective) degrees of freedom used.</p>
        <media xlink:href="jmir_v23i11e30394_app11.png" xlink:title="PNG File , 325 KB"/>
      </supplementary-material>
      <supplementary-material id="app12">
        <label>Multimedia Appendix 12</label>
        <p>Pairwise associations for &#60;italic&#62;Two Minute Walk&#60;/italic&#62; of the mean age, first score, fifth score, log-transformed number of repetitions performed, last score, and the difference from the fifth to the last score and their respective histograms (n=171 patients).</p>
        <media xlink:href="jmir_v23i11e30394_app12.png" xlink:title="PNG File , 339 KB"/>
      </supplementary-material>
      <supplementary-material id="app13">
        <label>Multimedia Appendix 13</label>
        <p>Linear quantile regression for &#60;italic&#62;Two Minute Walk&#60;/italic&#62; up to the fifth repetition. Comparison of baseline performance and linear slope of low (5th and 25th percentiles), median, and high performers (75th and 95th percentiles). Quantile regression &#60;italic&#62;P&#60;/italic&#62; values are Bonferroni-adjusted (n=855 tests).</p>
        <media xlink:href="jmir_v23i11e30394_app13.png" xlink:title="PNG File , 303 KB"/>
      </supplementary-material>
      <supplementary-material id="app14">
        <label>Multimedia Appendix 14</label>
        <p>Pairwise associations for &#60;italic&#62;U-Turn&#60;/italic&#62; of the mean age, first score, fifth score, log-transformed number of repetitions performed, last score, and the difference from the fifth to the last score and their respective histograms (n=217 patients).</p>
        <media xlink:href="jmir_v23i11e30394_app14.png" xlink:title="PNG File , 346 KB"/>
      </supplementary-material>
      <supplementary-material id="app15">
        <label>Multimedia Appendix 15</label>
        <p>Linear quantile regression for &#60;italic&#62;U-Turn&#60;/italic&#62; of short-term learning effects up to the fifth repetition. Comparison of baseline performance and linear slope of low (5th and 25th percentiles), median, and high performers (75th and 95th percentiles). Quantile regression &#60;italic&#62;P&#60;/italic&#62; values are Bonferroni-adjusted (n=1085 tests).</p>
        <media xlink:href="jmir_v23i11e30394_app15.png" xlink:title="PNG File , 358 KB"/>
      </supplementary-material>
      <supplementary-material id="app16">
        <label>Multimedia Appendix 16</label>
        <p>Pairwise associations for &#60;italic&#62;Static Balance&#60;/italic&#62; of the mean age, first score, fifth score, log-transformed number of repetitions performed, last score, and the difference from the fifth to the last score and their respective histograms (n=257 patients).</p>
        <media xlink:href="jmir_v23i11e30394_app16.png" xlink:title="PNG File , 298 KB"/>
      </supplementary-material>
      <supplementary-material id="app17">
        <label>Multimedia Appendix 17</label>
        <p>Linear quantile regression for &#60;italic&#62;Static Balance&#60;/italic&#62; of short-term learning effects up to the fifth repetition (a smaller sway path is better). Comparison of baseline performance and linear slope of low (5th and 25th percentiles), median, and high performers (75th and 95th percentiles). Quantile regression &#60;italic&#62;P&#60;/italic&#62; values are Bonferroni-adjusted (n=1285 tests).</p>
        <media xlink:href="jmir_v23i11e30394_app17.png" xlink:title="PNG File , 345 KB"/>
      </supplementary-material>
      <supplementary-material id="app18">
        <label>Multimedia Appendix 18</label>
        <p>Key results for the main analysis versus sensitivity analyses 1-3 for cognition, dexterity, and mobility.</p>
        <media xlink:href="jmir_v23i11e30394_app18.pdf" xlink:title="PDF File  (Adobe PDF File), 754 KB"/>
      </supplementary-material>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term id="abb1">9HPT</term>
          <def>
            <p>9-hole peg test</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb2">ANOVA</term>
          <def>
            <p>analysis of variance</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb3">
            <italic>e-SDMT</italic>
          </term>
          <def>
            <p>
              <italic>electronic Symbol Digit Modalities Test</italic>
            </p>
          </def>
        </def-item>
        <def-item>
          <term id="abb4">MS</term>
          <def>
            <p>multiple sclerosis</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb5">RMSE</term>
          <def>
            <p>root mean squared error</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb6">SDMT</term>
          <def>
            <p>Symbol Digit Modalities Test</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb7">T25FW</term>
          <def>
            <p>timed 25-foot walk</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <p>The authors thank all the participants of the Floodlight Open study for their participation and Roche for making the data set publicly available.</p>
    </ack>
    <fn-group>
      <fn fn-type="con">
        <p>TW designed the study, performed the analysis, interpreted the data, and drafted and revised the manuscript. JL designed the study, interpreted the data, and revised the manuscript. TW and JL had full access to the available source data and guaranteed the integrity of the analysis. SP, AW, LK, and YN helped interpret the data and revised the manuscript for important intellectual content.</p>
      </fn>
      <fn fn-type="conflict">
        <p>The research activities of the Research Center for Neuroimmunology and Neuroscience Basel, the affiliation of TW, SP, LK, YN, and JL, are supported by the University Hospital Basel, the University of Basel, and by grants from Novartis and Roche. One of the main projects of Research Center for Neuroimmunology and Neuroscience Basel is the development of a new comprehensive MS digital solution. TW and SP report no further conflicts of interest. AW reports no conflicts of interest. The University Hospital Basel, as the employer of LK, has received and dedicated to research support fees for board membership, consultancy or speaking, or grants in the past 3 years from Actelion, Bayer, Biogen Idec, CSL Behring, Eli Lilly EU, Genmab, GeNeuro SA, Janssen, Merck Serono, Novartis, Roche, Santhera, Sanofi-Aventis, Teva, European Union, Innosuisse, Roche Research Foundation, Swiss MS Society, and Swiss National Research Foundation. The University Hospital Basel, as the employer of YN, has received financial support for lectures from Teva and Celgene and grant support from Innosuisse (Swiss Innovation Agency). JL received research support from Innosuisse, Biogen, and Novartis; he received speaker honoraria and/or served on advisory boards for Biogen, Novartis, Roche, and Teva.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Browne</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Chandraratna</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Angood</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Tremlett</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Baker</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Taylor</surname>
              <given-names>BV</given-names>
            </name>
            <name name-style="western">
              <surname>Thompson</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Atlas of Multiple Sclerosis 2013: a growing global problem with widespread inequity</article-title>
          <source>Neurology</source>
          <year>2014</year>
          <month>09</month>
          <day>09</day>
          <volume>83</volume>
          <issue>11</issue>
          <fpage>1022</fpage>
          <lpage>4</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/25200713"/>
          </comment>
          <pub-id pub-id-type="doi">10.1212/WNL.0000000000000768</pub-id>
          <pub-id pub-id-type="medline">25200713</pub-id>
          <pub-id pub-id-type="pii">WNL.0000000000000768</pub-id>
          <pub-id pub-id-type="pmcid">PMC4162299</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kingwell</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Marriott</surname>
              <given-names>JJ</given-names>
            </name>
            <name name-style="western">
              <surname>Jetté</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Pringsheim</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Makhani</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Morrow</surname>
              <given-names>SA</given-names>
            </name>
            <name name-style="western">
              <surname>Fisk</surname>
              <given-names>JD</given-names>
            </name>
            <name name-style="western">
              <surname>Evans</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Béland</surname>
              <given-names>SG</given-names>
            </name>
            <name name-style="western">
              <surname>Kulaga</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Dykeman</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Wolfson</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Koch</surname>
              <given-names>MW</given-names>
            </name>
            <name name-style="western">
              <surname>Marrie</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Incidence and prevalence of multiple sclerosis in europe: a systematic review</article-title>
          <source>BMC Neurol</source>
          <year>2013</year>
          <month>09</month>
          <day>26</day>
          <volume>13</volume>
          <fpage>128</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://bmcneurol.biomedcentral.com/articles/10.1186/1471-2377-13-128"/>
          </comment>
          <pub-id pub-id-type="doi">10.1186/1471-2377-13-128</pub-id>
          <pub-id pub-id-type="medline">24070256</pub-id>
          <pub-id pub-id-type="pii">1471-2377-13-128</pub-id>
          <pub-id pub-id-type="pmcid">PMC3856596</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Rao</surname>
              <given-names>SM</given-names>
            </name>
            <collab>Cognitive Function Study Group of the National Multiple Sclerosis Society</collab>
          </person-group>
          <article-title>A manual for the brief repeatable battery of neuropsychological tests in multiple sclerosis</article-title>
          <source>Medical College of Wisconsin, Milwaukee, WI</source>
          <year>1990</year>
          <access-date>2020-10-07</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://scholar.google.com/scholar_lookup?title=A%20manual%20for%20the%20brief%20repeatable%20battery%20of%20neuropsychological%20tests%20in%20multiple%20sclerosis&#38;publication_year=1990">https://scholar.google.com/scholar_lookup?title=A%20manual%20for%20the%20brief%20repeatable%20 battery%20of%20neuropsychological%20tests%20in%20multiple%20sclerosis&#38;publication_year=1990</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Parmenter</surname>
              <given-names>BA</given-names>
            </name>
            <name name-style="western">
              <surname>Weinstock-Guttman</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Garg</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Munschauer</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Benedict</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <article-title>Screening for cognitive impairment in multiple sclerosis using the symbol digit modalities test</article-title>
          <source>Mult Scler</source>
          <year>2007</year>
          <month>01</month>
          <volume>13</volume>
          <issue>1</issue>
          <fpage>52</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1177/1352458506070750</pub-id>
          <pub-id pub-id-type="medline">17294611</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Goodkin</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Hertsgaard</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Seminary</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests</article-title>
          <source>Arch Phys Med Rehabil</source>
          <year>1988</year>
          <month>10</month>
          <volume>69</volume>
          <issue>10</issue>
          <fpage>850</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.5555/URI:PII:0003999388900093</pub-id>
          <pub-id pub-id-type="medline">3178453</pub-id>
          <pub-id pub-id-type="pii">0003-9993(88)90009-3</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Feys</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Lamers</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Francis</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Benedict</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Phillips</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>LaRocca</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Hudson</surname>
              <given-names>LD</given-names>
            </name>
            <name name-style="western">
              <surname>Rudick</surname>
              <given-names>R</given-names>
            </name>
            <collab>Multiple Sclerosis Outcome Assessments Consortium</collab>
          </person-group>
          <article-title>The nine-hole peg test as a manual dexterity performance measure for multiple sclerosis</article-title>
          <source>Mult Scler</source>
          <year>2017</year>
          <month>04</month>
          <volume>23</volume>
          <issue>5</issue>
          <fpage>711</fpage>
          <lpage>20</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://journals.sagepub.com/doi/10.1177/1352458517690824?url_ver=Z39.88-2003&#38;rfr_id=ori:rid:crossref.org&#38;rfr_dat=cr_pub%3dpubmed"/>
          </comment>
          <pub-id pub-id-type="doi">10.1177/1352458517690824</pub-id>
          <pub-id pub-id-type="medline">28206826</pub-id>
          <pub-id pub-id-type="pmcid">PMC5405844</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Motl</surname>
              <given-names>RW</given-names>
            </name>
            <name name-style="western">
              <surname>Cohen</surname>
              <given-names>JA</given-names>
            </name>
            <name name-style="western">
              <surname>Benedict</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Phillips</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>LaRocca</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Hudson</surname>
              <given-names>LD</given-names>
            </name>
            <name name-style="western">
              <surname>Rudick</surname>
              <given-names>R</given-names>
            </name>
            <collab>Multiple Sclerosis Outcome Assessments Consortium</collab>
          </person-group>
          <article-title>Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis</article-title>
          <source>Mult Scler</source>
          <year>2017</year>
          <month>04</month>
          <volume>23</volume>
          <issue>5</issue>
          <fpage>704</fpage>
          <lpage>10</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://journals.sagepub.com/doi/10.1177/1352458517690823?url_ver=Z39.88-2003&#38;rfr_id=ori:rid:crossref.org&#38;rfr_dat=cr_pub%3dpubmed"/>
          </comment>
          <pub-id pub-id-type="doi">10.1177/1352458517690823</pub-id>
          <pub-id pub-id-type="medline">28206828</pub-id>
          <pub-id pub-id-type="pmcid">PMC5405807</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>D'Souza</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Papadopoulou</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Girardey</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Kappos</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Standardization and digitization of clinical data in multiple sclerosis</article-title>
          <source>Nat Rev Neurol</source>
          <year>2021</year>
          <month>02</month>
          <volume>17</volume>
          <issue>2</issue>
          <fpage>119</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="doi">10.1038/s41582-020-00448-7</pub-id>
          <pub-id pub-id-type="medline">33452493</pub-id>
          <pub-id pub-id-type="pii">10.1038/s41582-020-00448-7</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Montalban</surname>
              <given-names>X</given-names>
            </name>
            <name name-style="western">
              <surname>Graves</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Midaglia</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Mulero</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Julian</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Baker</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Schadrack</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Gossens</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Ganzetti</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Scotland</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Lipsmeier</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>van Beek</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Bernasconi</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Belachew</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Lindemann</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Hauser</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>A smartphone sensor-based digital outcome assessment of multiple sclerosis</article-title>
          <source>Mult Scler</source>
          <year>2021</year>
          <month>07</month>
          <day>14</day>
          <fpage>13524585211028561</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://journals.sagepub.com/doi/10.1177/13524585211028561?url_ver=Z39.88-2003&#38;rfr_id=ori:rid:crossref.org&#38;rfr_dat=cr_pub%3dpubmed"/>
          </comment>
          <pub-id pub-id-type="doi">10.1177/13524585211028561</pub-id>
          <pub-id pub-id-type="medline">34259588</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Lipsmeier</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Taylor</surname>
              <given-names>KI</given-names>
            </name>
            <name name-style="western">
              <surname>Kilchenmann</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Wolf</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Scotland</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Schjodt-Eriksen</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Cheng</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Fernandez-Garcia</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Siebourg-Polster</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Jin</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Soto</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Verselis</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Boess</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Koller</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Grundman</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Monsch</surname>
              <given-names>AU</given-names>
            </name>
            <name name-style="western">
              <surname>Postuma</surname>
              <given-names>RB</given-names>
            </name>
            <name name-style="western">
              <surname>Ghosh</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Kremer</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Czech</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Gossens</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Lindemann</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial</article-title>
          <source>Mov Disord</source>
          <year>2018</year>
          <month>08</month>
          <volume>33</volume>
          <issue>8</issue>
          <fpage>1287</fpage>
          <lpage>97</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/29701258"/>
          </comment>
          <pub-id pub-id-type="doi">10.1002/mds.27376</pub-id>
          <pub-id pub-id-type="medline">29701258</pub-id>
          <pub-id pub-id-type="pmcid">PMC6175318</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <nlm-citation citation-type="confproc">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Tortelli</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Simillion</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Lipsmeier</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Kilchenmann</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Rodrigues</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Byrne</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Bamdadian</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Gossens</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Schobel</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Lindemann</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Wild</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>The Digital-HD study: smartphone-based remote testing to assess cognitive and motor symptoms in Huntington’s disease (1816)</article-title>
          <source>Proceedings of the American Academy of Neurology Annual Meeting</source>
          <year>2020</year>
          <month>04</month>
          <day>14</day>
          <conf-name>American Academy of Neurology Annual Meeting</conf-name>
          <conf-date>April 25-May 1, 2020</conf-date>
          <conf-loc>Online</conf-loc>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://n.neurology.org/content/94/15_Supplement/1816"/>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Alexander</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Peryer</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Gray</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Barkhof</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Chataway</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Wearable technologies to measure clinical outcomes in multiple sclerosis: a scoping review</article-title>
          <source>Mult Scler</source>
          <year>2021</year>
          <month>10</month>
          <volume>27</volume>
          <issue>11</issue>
          <fpage>1643</fpage>
          <lpage>56</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://journals.sagepub.com/doi/10.1177/1352458520946005?url_ver=Z39.88-2003&#38;rfr_id=ori:rid:crossref.org&#38;rfr_dat=cr_pub%3dpubmed"/>
          </comment>
          <pub-id pub-id-type="doi">10.1177/1352458520946005</pub-id>
          <pub-id pub-id-type="medline">32749928</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Lam</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Meijer</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Loonstra</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Coerver</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Twose</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Redeman</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Moraal</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Barkhof</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>de Groot</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Uitdehaag</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Killestein</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis</article-title>
          <source>Mult Scler</source>
          <year>2021</year>
          <month>08</month>
          <volume>27</volume>
          <issue>9</issue>
          <fpage>1421</fpage>
          <lpage>31</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://journals.sagepub.com/doi/10.1177/1352458520968797?url_ver=Z39.88-2003&#38;rfr_id=ori:rid:crossref.org&#38;rfr_dat=cr_pub%3dpubmed"/>
          </comment>
          <pub-id pub-id-type="doi">10.1177/1352458520968797</pub-id>
          <pub-id pub-id-type="medline">33150823</pub-id>
          <pub-id pub-id-type="pmcid">PMC8358561</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bove</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>White</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Giovannoni</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Glanz</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Golubchikov</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Hujol</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Jennings</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Langdon</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Lee</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Legedza</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Paskavitz</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Prasad</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Richert</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Robbins</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Roberts</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Weiner</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Ramachandran</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Botfield</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>De Jager</surname>
              <given-names>PL</given-names>
            </name>
          </person-group>
          <article-title>Evaluating more naturalistic outcome measures: a 1-year smartphone study in multiple sclerosis</article-title>
          <source>Neurol Neuroimmunol Neuroinflamm</source>
          <year>2015</year>
          <month>10</month>
          <day>15</day>
          <volume>2</volume>
          <issue>6</issue>
          <fpage>e162</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://nn.neurology.org/cgi/pmidlookup?view=long&#38;pmid=26516627"/>
          </comment>
          <pub-id pub-id-type="doi">10.1212/NXI.0000000000000162</pub-id>
          <pub-id pub-id-type="medline">26516627</pub-id>
          <pub-id pub-id-type="pii">NEURIMMINFL2015006155</pub-id>
          <pub-id pub-id-type="pmcid">PMC4608760</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bradshaw</surname>
              <given-names>MJ</given-names>
            </name>
            <name name-style="western">
              <surname>Farrow</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Motl</surname>
              <given-names>RW</given-names>
            </name>
            <name name-style="western">
              <surname>Chitnis</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Wearable biosensors to monitor disability in multiple sclerosis</article-title>
          <source>Neurol Clin Pract</source>
          <year>2017</year>
          <month>08</month>
          <volume>7</volume>
          <issue>4</issue>
          <fpage>354</fpage>
          <lpage>62</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/29185551"/>
          </comment>
          <pub-id pub-id-type="doi">10.1212/CPJ.0000000000000382</pub-id>
          <pub-id pub-id-type="medline">29185551</pub-id>
          <pub-id pub-id-type="pii">NEURCLINPRACT2016020073</pub-id>
          <pub-id pub-id-type="pmcid">PMC5648206</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Akhbardeh</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Arjona</surname>
              <given-names>JK</given-names>
            </name>
            <name name-style="western">
              <surname>Krysko</surname>
              <given-names>KM</given-names>
            </name>
            <name name-style="western">
              <surname>Nourbakhsh</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Gourraud</surname>
              <given-names>PA</given-names>
            </name>
            <name name-style="western">
              <surname>Graves</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Novel MS vital sign: multi-sensor captures upper and lower limb dysfunction</article-title>
          <source>Ann Clin Transl Neurol</source>
          <year>2020</year>
          <month>03</month>
          <volume>7</volume>
          <issue>3</issue>
          <fpage>288</fpage>
          <lpage>95</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://doi.org/10.1002/acn3.50988"/>
          </comment>
          <pub-id pub-id-type="doi">10.1002/acn3.50988</pub-id>
          <pub-id pub-id-type="medline">32101388</pub-id>
          <pub-id pub-id-type="pmcid">PMC7085995</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Midaglia</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Mulero</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Montalban</surname>
              <given-names>X</given-names>
            </name>
            <name name-style="western">
              <surname>Graves</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Hauser</surname>
              <given-names>SL</given-names>
            </name>
            <name name-style="western">
              <surname>Julian</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Baker</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Schadrack</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Gossens</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Scotland</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Lipsmeier</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>van Beek</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Bernasconi</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Belachew</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Lindemann</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study</article-title>
          <source>J Med Internet Res</source>
          <year>2019</year>
          <month>08</month>
          <day>30</day>
          <volume>21</volume>
          <issue>8</issue>
          <fpage>e14863</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jmir.org/2019/8/e14863/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/14863</pub-id>
          <pub-id pub-id-type="medline">31471961</pub-id>
          <pub-id pub-id-type="pii">v21i8e14863</pub-id>
          <pub-id pub-id-type="pmcid">PMC6743265</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Koh</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Lu</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Chen</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Hsueh</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Hsieh</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Hsieh</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Test-retest reliability and practice effect of the oral-format symbol digit modalities test in patients with stroke</article-title>
          <source>Arch Clin Neuropsychol</source>
          <year>2011</year>
          <month>06</month>
          <volume>26</volume>
          <issue>4</issue>
          <fpage>356</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1093/arclin/acr029</pub-id>
          <pub-id pub-id-type="medline">21555787</pub-id>
          <pub-id pub-id-type="pii">acr029</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Erlanger</surname>
              <given-names>DM</given-names>
            </name>
            <name name-style="western">
              <surname>Kaushik</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Caruso</surname>
              <given-names>LS</given-names>
            </name>
            <name name-style="western">
              <surname>Benedict</surname>
              <given-names>RH</given-names>
            </name>
            <name name-style="western">
              <surname>Foley</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Wilken</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Cadavid</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Deluca</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial</article-title>
          <source>J Neurol Sci</source>
          <year>2014</year>
          <month>05</month>
          <day>15</day>
          <volume>340</volume>
          <issue>1-2</issue>
          <fpage>123</fpage>
          <lpage>9</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S0022-510X(14)00153-1"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.jns.2014.03.009</pub-id>
          <pub-id pub-id-type="medline">24656433</pub-id>
          <pub-id pub-id-type="pii">S0022-510X(14)00153-1</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Benedict</surname>
              <given-names>RH</given-names>
            </name>
            <name name-style="western">
              <surname>Cohan</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Lynch</surname>
              <given-names>SG</given-names>
            </name>
            <name name-style="western">
              <surname>Riester</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Wang</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Castro-Borrero</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Elkins</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Sabatella</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: results from the DECIDE study</article-title>
          <source>Mult Scler</source>
          <year>2018</year>
          <month>05</month>
          <volume>24</volume>
          <issue>6</issue>
          <fpage>795</fpage>
          <lpage>804</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://journals.sagepub.com/doi/10.1177/1352458517707345?url_ver=Z39.88-2003&#38;rfr_id=ori:rid:crossref.org&#38;rfr_dat=cr_pub%3dpubmed"/>
          </comment>
          <pub-id pub-id-type="doi">10.1177/1352458517707345</pub-id>
          <pub-id pub-id-type="medline">28485186</pub-id>
          <pub-id pub-id-type="pmcid">PMC5971365</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Cohen</surname>
              <given-names>JA</given-names>
            </name>
            <name name-style="western">
              <surname>Cutter</surname>
              <given-names>GR</given-names>
            </name>
            <name name-style="western">
              <surname>Fischer</surname>
              <given-names>JS</given-names>
            </name>
            <name name-style="western">
              <surname>Goodman</surname>
              <given-names>AD</given-names>
            </name>
            <name name-style="western">
              <surname>Heidenreich</surname>
              <given-names>FR</given-names>
            </name>
            <name name-style="western">
              <surname>Jak</surname>
              <given-names>AJ</given-names>
            </name>
            <name name-style="western">
              <surname>Kniker</surname>
              <given-names>JE</given-names>
            </name>
            <name name-style="western">
              <surname>Kooijmans</surname>
              <given-names>MF</given-names>
            </name>
            <name name-style="western">
              <surname>Lull</surname>
              <given-names>JM</given-names>
            </name>
            <name name-style="western">
              <surname>Sandrock</surname>
              <given-names>AW</given-names>
            </name>
            <name name-style="western">
              <surname>Simon</surname>
              <given-names>JH</given-names>
            </name>
            <name name-style="western">
              <surname>Simonian</surname>
              <given-names>NA</given-names>
            </name>
            <name name-style="western">
              <surname>Whitaker</surname>
              <given-names>JN</given-names>
            </name>
          </person-group>
          <article-title>Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial</article-title>
          <source>Arch Neurol</source>
          <year>2001</year>
          <month>06</month>
          <volume>58</volume>
          <issue>6</issue>
          <fpage>961</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.58.6.961</pub-id>
          <pub-id pub-id-type="medline">11405811</pub-id>
          <pub-id pub-id-type="pii">noc00270</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <nlm-citation citation-type="confproc">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>van Beek</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Freitas</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Bernasconi</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Montalban</surname>
              <given-names>X</given-names>
            </name>
            <name name-style="western">
              <surname>Butzkueven</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Kappos</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Oh</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Giovannoni</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Bove</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Julian</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Baker</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Lindemann</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>FLOODLIGHT Open - A global, prospective, open-access study to better understand multiple sclerosis using smartphone technology</article-title>
          <source>Proceedings of the Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC)</source>
          <year>2019</year>
          <conf-name>Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC)</conf-name>
          <conf-date>May 28–June 1, 2019</conf-date>
          <conf-loc>Seattle, Washington, USA</conf-loc>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://cmsc.confex.com/cmsc/2019/mediafile/Handout/Paper5900/QOL10_CMSC%202019%20FLOODLIGHT%20Open%20Poster_Global_van%20Beek%20et%20alFINA.pdf"/>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Schwab</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Karlen</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>A deep learning approach to diagnosing multiple sclerosis from smartphone data</article-title>
          <source>IEEE J Biomed Health Inform</source>
          <year>2021</year>
          <month>04</month>
          <volume>25</volume>
          <issue>4</issue>
          <fpage>1284</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="doi">10.1109/JBHI.2020.3021143</pub-id>
          <pub-id pub-id-type="medline">32877343</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Solari</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Radice</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Manneschi</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Motti</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Montanari</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>The multiple sclerosis functional composite: different practice effects in the three test components</article-title>
          <source>J Neurol Sci</source>
          <year>2005</year>
          <month>01</month>
          <day>15</day>
          <volume>228</volume>
          <issue>1</issue>
          <fpage>71</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jns.2004.09.033</pub-id>
          <pub-id pub-id-type="medline">15607213</pub-id>
          <pub-id pub-id-type="pii">S0022-510X(04)00357-0</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref25">
        <label>25</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Wood</surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
          <article-title>Stable and efficient multiple smoothing parameter estimation for generalized additive models</article-title>
          <source>J Am Stat Assoc</source>
          <year>2004</year>
          <month>09</month>
          <volume>99</volume>
          <issue>467</issue>
          <fpage>673</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="doi">10.1198/016214504000000980</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref26">
        <label>26</label>
        <nlm-citation citation-type="book">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Wood</surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
          <source>Generalized Additive Models: An Introduction with R</source>
          <year>2017</year>
          <publisher-loc>Boca Raton</publisher-loc>
          <publisher-name>Chapman and Hall/CRC</publisher-name>
        </nlm-citation>
      </ref>
      <ref id="ref27">
        <label>27</label>
        <nlm-citation citation-type="web">
          <article-title>timwoelfle / MS-Practice-Effects</article-title>
          <source>GitHub</source>
          <access-date>2021-11-02</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://github.com/timwoelfle/MS-Practice-Effects">https://github.com/timwoelfle/MS-Practice-Effects</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref28">
        <label>28</label>
        <nlm-citation citation-type="web">
          <article-title>Complete dataset</article-title>
          <source>Floodlight Open</source>
          <access-date>2021-11-02</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://dataset.floodlightopen.com/public-blobs-prod/complete_dataset.csv">https://dataset.floodlightopen.com/public-blobs-prod/complete_dataset.csv</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref29">
        <label>29</label>
        <nlm-citation citation-type="confproc">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Liao</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Moor</surname>
              <given-names>CD</given-names>
            </name>
            <name name-style="western">
              <surname>Williams</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Fisher</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Rao</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Real-world practice effects and effect modifiers of neuroperformance tests in multiple sclerosis partners advancing technology and health solutions (MS PATHS) (4135)</article-title>
          <source>Proceedings of the American Academy of Neurology Annual Meeting</source>
          <year>2021</year>
          <conf-name>American Academy of Neurology Annual Meeting</conf-name>
          <conf-date>2021</conf-date>
          <conf-loc>Online</conf-loc>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://n.neurology.org/content/96/15_Supplement/4135"/>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref30">
        <label>30</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Morrow</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>O'Connor</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Polman</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Goodman</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Kappos</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Lublin</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Rudick</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Jurgensen</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Paes</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Forrestal</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Benedict</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks</article-title>
          <source>Mult Scler</source>
          <year>2010</year>
          <month>11</month>
          <volume>16</volume>
          <issue>11</issue>
          <fpage>1385</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="doi">10.1177/1352458510378021</pub-id>
          <pub-id pub-id-type="medline">20739335</pub-id>
          <pub-id pub-id-type="pii">1352458510378021</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref31">
        <label>31</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Benedict</surname>
              <given-names>RH</given-names>
            </name>
            <name name-style="western">
              <surname>Duquin</surname>
              <given-names>JA</given-names>
            </name>
            <name name-style="western">
              <surname>Jurgensen</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Rudick</surname>
              <given-names>RA</given-names>
            </name>
            <name name-style="western">
              <surname>Feitcher</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Munschauer</surname>
              <given-names>FE</given-names>
            </name>
            <name name-style="western">
              <surname>Panzara</surname>
              <given-names>MA</given-names>
            </name>
            <name name-style="western">
              <surname>Weinstock-Guttman</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Repeated assessment of neuropsychological deficits in multiple sclerosis using the symbol digit modalities test and the MS neuropsychological screening questionnaire</article-title>
          <source>Mult Scler</source>
          <year>2008</year>
          <month>08</month>
          <volume>14</volume>
          <issue>7</issue>
          <fpage>940</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1177/1352458508090923</pub-id>
          <pub-id pub-id-type="medline">18573822</pub-id>
          <pub-id pub-id-type="pii">1352458508090923</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref32">
        <label>32</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Roar</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Illes</surname>
              <given-names>Z</given-names>
            </name>
            <name name-style="western">
              <surname>Sejbaek</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Practice effect in symbol digit modalities test in multiple sclerosis patients treated with natalizumab</article-title>
          <source>Mult Scler Relat Disord</source>
          <year>2016</year>
          <month>11</month>
          <volume>10</volume>
          <fpage>116</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="doi">10.1016/j.msard.2016.09.009</pub-id>
          <pub-id pub-id-type="medline">27919477</pub-id>
          <pub-id pub-id-type="pii">S2211-0348(16)30172-9</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref33">
        <label>33</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Benedict</surname>
              <given-names>RH</given-names>
            </name>
            <name name-style="western">
              <surname>Smerbeck</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Parikh</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Rodgers</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Cadavid</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Erlanger</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Reliability and equivalence of alternate forms for the symbol digit modalities test: implications for multiple sclerosis clinical trials</article-title>
          <source>Mult Scler</source>
          <year>2012</year>
          <month>09</month>
          <volume>18</volume>
          <issue>9</issue>
          <fpage>1320</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1177/1352458511435717</pub-id>
          <pub-id pub-id-type="medline">22277740</pub-id>
          <pub-id pub-id-type="pii">1352458511435717</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref34">
        <label>34</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Benedict</surname>
              <given-names>RH</given-names>
            </name>
            <name name-style="western">
              <surname>DeLuca</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Phillips</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>LaRocca</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Hudson</surname>
              <given-names>LD</given-names>
            </name>
            <name name-style="western">
              <surname>Rudick</surname>
              <given-names>R</given-names>
            </name>
            <collab>Multiple Sclerosis Outcome Assessments Consortium</collab>
          </person-group>
          <article-title>Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis</article-title>
          <source>Mult Scler</source>
          <year>2017</year>
          <month>04</month>
          <volume>23</volume>
          <issue>5</issue>
          <fpage>721</fpage>
          <lpage>33</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://journals.sagepub.com/doi/10.1177/1352458517690821?url_ver=Z39.88-2003&#38;rfr_id=ori:rid:crossref.org&#38;rfr_dat=cr_pub%3dpubmed"/>
          </comment>
          <pub-id pub-id-type="doi">10.1177/1352458517690821</pub-id>
          <pub-id pub-id-type="medline">28206827</pub-id>
          <pub-id pub-id-type="pmcid">PMC5405816</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref35">
        <label>35</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Cohen</surname>
              <given-names>JA</given-names>
            </name>
            <name name-style="western">
              <surname>Fischer</surname>
              <given-names>JS</given-names>
            </name>
            <name name-style="western">
              <surname>Bolibrush</surname>
              <given-names>DM</given-names>
            </name>
            <name name-style="western">
              <surname>Jak</surname>
              <given-names>AJ</given-names>
            </name>
            <name name-style="western">
              <surname>Kniker</surname>
              <given-names>JE</given-names>
            </name>
            <name name-style="western">
              <surname>Mertz</surname>
              <given-names>LA</given-names>
            </name>
            <name name-style="western">
              <surname>Skaramagas</surname>
              <given-names>TT</given-names>
            </name>
            <name name-style="western">
              <surname>Cutter</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Intrarater and interrater reliability of the MS functional composite outcome measure</article-title>
          <source>Neurology</source>
          <year>2000</year>
          <month>02</month>
          <day>22</day>
          <volume>54</volume>
          <issue>4</issue>
          <fpage>802</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1212/wnl.54.4.802</pub-id>
          <pub-id pub-id-type="medline">10690966</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref36">
        <label>36</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Maillart</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Labauge</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Cohen</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Maarouf</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Vukusic</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Donzé</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Gallien</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>De Sèze</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Bourre</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Moreau</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Louapre</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Mayran</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Bieuvelet</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Vallée</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Bertillot</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Klaeylé</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Argoud</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Zinaï</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Tourbah</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>MSCopilot, a new multiple sclerosis self-assessment digital solution: results of a comparative study versus standard tests</article-title>
          <source>Eur J Neurol</source>
          <year>2020</year>
          <month>03</month>
          <volume>27</volume>
          <issue>3</issue>
          <fpage>429</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="doi">10.1111/ene.14091</pub-id>
          <pub-id pub-id-type="medline">31538396</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref37">
        <label>37</label>
        <nlm-citation citation-type="confproc">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Pelletier</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Rennert</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Chang</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Decunto</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Cen</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>myMS: a comprehensive patient-centered mobile app to monitor MS at home (P32-003)</article-title>
          <source>Proceedings of the American Academy of Neurology Annual Meeting</source>
          <year>2019</year>
          <month>07</month>
          <day>05</day>
          <conf-name>American Academy of Neurology Annual Meeting</conf-name>
          <conf-date>2019</conf-date>
          <conf-loc>Pennsylvania, Philadelphia, USA</conf-loc>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://n.neurology.org/content/92/15_Supplement/P3.2-003"/>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref38">
        <label>38</label>
        <nlm-citation citation-type="confproc">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Guo</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Cahir-Mcfarland</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Dumail</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Guymard</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Mcloughlin</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Bieuvelet</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Vallée</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Zinai</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Beynon</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Scaramozza</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Franchimont</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Belachew</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Konectom™ digital smartphone based assessment of cognitive and motor functional performance in multiple sclerosis</article-title>
          <source>Proceedings of the MS Virtual 2020 Conference</source>
          <year>2021</year>
          <month>04</month>
          <conf-name>MS Virtual 2020 Conference</conf-name>
          <conf-date>December 1, 2020</conf-date>
          <conf-loc>Online</conf-loc>
          <fpage>S121</fpage>
          <pub-id pub-id-type="doi">10.1016/j.neurol.2021.02.360</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref39">
        <label>39</label>
        <nlm-citation citation-type="confproc">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Naegelin</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Lorscheider</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Woelfle</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Pless</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Kuhle</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Reyes</surname>
              <given-names>O</given-names>
            </name>
            <name name-style="western">
              <surname>Wiencierz</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Kappos</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Dreams - Developing a comprehensive, sensitive and validated set of digital biomarkers for MS</article-title>
          <source>Proceedings of the MS Virtual 2020 Conference</source>
          <year>2020</year>
          <conf-name>MS Virtual 2020 Conference</conf-name>
          <conf-date>December 1, 2020</conf-date>
          <conf-loc>Online</conf-loc>
          <pub-id pub-id-type="doi">10.1177/1352458520974937</pub-id>
        </nlm-citation>
      </ref>
    </ref-list>
  </back>
</article>
